These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38538166)

  • 1. Failure to Terminate Ventricular Fibrillation With Multiple Implantable Cardioverter-Defibrillator Shocks Caused by Shock Polarity.
    Thomas G; Cheung JW
    JACC Clin Electrophysiol; 2024 Mar; 10(3):611-619. PubMed ID: 38538166
    [No Abstract]   [Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing].
    Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitachycardia pacing therapy for the successful treatment of lead fracture.
    Bhimani AA; Deeprasertkul P; Nannapaneni N; Carayannopoulos GN
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):228-9. PubMed ID: 25354719
    [No Abstract]   [Full Text] [Related]  

  • 5. Catastrophic failure of Durata ICD lead due to high-voltage short during shock delivery.
    Schloss EJ; Krebs ME; Gupta M
    Heart Rhythm; 2014 Oct; 11(10):1733-4. PubMed ID: 24931635
    [No Abstract]   [Full Text] [Related]  

  • 6. High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation.
    Moubarak JB; Karasik PE; Fletcher RD; Franz MR
    J Am Coll Cardiol; 2000 Feb; 35(2):422-7. PubMed ID: 10676690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable cardioverter-defibrillator therapy before death: high risk for painful shocks at end of life.
    Kinch Westerdahl A; Sjöblom J; Mattiasson AC; Rosenqvist M; Frykman V
    Circulation; 2014 Jan; 129(4):422-9. PubMed ID: 24243857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inappropriate implantable cardioverter-defibrillator therapy due to the detection of premature ventricular complexes.
    Goldberger JJ; Horvath G; Challapalli R; Kadish AH
    Pacing Clin Electrophysiol; 1999 May; 22(5):825-8. PubMed ID: 10353148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator shocks in dying patients: disturbing data from beyond the grave.
    Lampert R
    Circulation; 2014 Jan; 129(4):414-6. PubMed ID: 24243856
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous Implantable Cardioverter Defibrillator Lead Repositioning for Preventing Inappropriate Shocks Due to Myopotential Oversensing in a Post-Fulminant Myocarditis Patient.
    Sasaki T; Nakamura K; Naito S
    Int Heart J; 2019 Mar; 60(2):466-469. PubMed ID: 30745542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case.
    Nakao Y; Suenari K; Yamashiro K; Nakagawa H; Shiode N
    BMC Cardiovasc Disord; 2020 Mar; 20(1):134. PubMed ID: 32169057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Kulkarni N; Link MS
    Card Electrophysiol Clin; 2018 Mar; 10(1):67-74. PubMed ID: 29428143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent clinical experience with the automatic implantable cardioverter-defibrillator.
    Mirowski M; Mower MM; Veltri EP; Juanteguy JM; Reid PR
    Cardiol Clin; 1985 Nov; 3(4):623-30. PubMed ID: 3910242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Termination of ventricular tachycardia by far-field stimulation in humans: a feasibility study.
    Lawo T; Schrader J; Buddensiek M; Schweika O; Mügge A; Bösche LI
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1540-7. PubMed ID: 21039638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
    Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
    J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate shock from a subcutaneous implantable cardioverter-defibrillator due to transcutaneous electrical nerve stimulation.
    Miller MA; Palaniswamy C; Sharma D; Reddy VY
    Heart Rhythm; 2015 Jul; 12(7):1702-3. PubMed ID: 25889810
    [No Abstract]   [Full Text] [Related]  

  • 18. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.
    Meissner MD; Lehmann MH; Steinman RT; Mosteller RD; Akhtar M; Calkins H; Cannom DS; Epstein AE; Fogoros RN; Liem LB
    J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
    Kuck KH
    Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
    [No Abstract]   [Full Text] [Related]  

  • 20. Repetitive shock therapy of subcutaneous implantable cardioverter defibrillators in a patient with idiopathic ventricular fibrillation: What is the mechanism?
    Hasegawa K; Miyazaki S; Ishikawa E; Mukai M; Aoyama D; Nodera M; Kaseno K; Tada H
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2121-2124. PubMed ID: 31332856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.